uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Onzeald
Refused
Human
Details
EMA number
EMEA/H/C/003874
ATC code
L01
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of breast cancer with brain metastases
MeSH:
Breast Neoplasms
Group:
Antineoplastic agents
Active substances
etirinotecan pegol
Marketing Authorisation Holder
Nektar Therapeutics UK Limited
MAH
Onzeald | uMedical